257 related articles for article (PubMed ID: 16554370)
1. Galactosamine prevents ethinylestradiol-induced cholestasis.
Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
[TBL] [Abstract][Full Text] [Related]
4. Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals.
Gregus Z; Madhu C; Goon D; Klaassen CD
Drug Metab Dispos; 1988; 16(4):527-33. PubMed ID: 2903018
[TBL] [Abstract][Full Text] [Related]
5. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
6. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
Accatino L; Pizarro M; Solís N; Koenig CS
Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets.
Crocenzi FA; Sánchez Pozzi EJ; Pellegrino JM; Favre CO; Rodríguez Garay EA; Mottino AD; Coleman R; Roma MG
Hepatology; 2001 Aug; 34(2):329-39. PubMed ID: 11481618
[TBL] [Abstract][Full Text] [Related]
8. Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
Gregus Z; Watkins JB; Thompson TN; Klaassen CD
J Pharmacol Exp Ther; 1983 May; 225(2):256-62. PubMed ID: 6405026
[TBL] [Abstract][Full Text] [Related]
9. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism.
Stramentinoli G; Di Padova C; Gualano M; Rovagnati P; Galli-Kienle M
Gastroenterology; 1981 Jan; 80(1):154-8. PubMed ID: 7450400
[TBL] [Abstract][Full Text] [Related]
10. Biliary secretion of glutathione in estradiol 17beta-D-glucuronide-induced cholestasis.
Mottino AD; Veggi LM; Wood M; Román JM; Vore M
J Pharmacol Exp Ther; 2003 Oct; 307(1):306-13. PubMed ID: 12893835
[TBL] [Abstract][Full Text] [Related]
11. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
Chrungoo VJ; Reen RK; Singh K; Singh J
Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
[TBL] [Abstract][Full Text] [Related]
12. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
13. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
14. Impairment of bile secretion induced by exhaustive exercise in the rat. Protective effects of S-adenosyl-L-methionine.
Villa JG; Almar MM; Collado PS; Llamazares E; González-Gallego J
Int J Sports Med; 1993 May; 14(4):179-84. PubMed ID: 8325715
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
Meyers M; Slikker W; Pascoe G; Vore M
J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis.
Hussein MA
J Med Food; 2013 Mar; 16(3):246-54. PubMed ID: 23305807
[TBL] [Abstract][Full Text] [Related]
17. MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver.
Liu Y; Huang L; Hoffman T; Gosland M; Vore M
Cancer Res; 1996 Nov; 56(21):4992-7. PubMed ID: 8895755
[TBL] [Abstract][Full Text] [Related]
18. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat.
Garduño-Siciliano L; Labarrios F; Tamariz J; Moreno MG; Chamorro G; Muriel P
Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448
[TBL] [Abstract][Full Text] [Related]
19. Hormone-induced bile flow and hepatobiliary calcium fluxes are attenuated in the perfused liver of rats made cholestatic with ethynylestradiol in vivo and with phalloidin in vitro.
Hamada Y; Karjalainen A; Bygrave FL
Hepatology; 1995 May; 21(5):1455-64. PubMed ID: 7737653
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-induced cholestasis results in a dramatic increase of b-series gangliosides in the rat liver.
Majer F; Trnka L; Vítek L; Jirkovská M; Marecek Z; Smíd F
Biomed Chromatogr; 2007 May; 21(5):446-50. PubMed ID: 17357127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
